Subscribe To
No pain, no gain
Long-term success is rarely achieved without some suffering. In other words, you are unlikely to enjoy ...
May 3, 2022, 4:46 pm
Irwin naturals posts record results for 2021 as core business continues to grow
Irwin Naturals Inc. (CSE:IWIN) has said it achieved record results for the financial year ended Decembe...
May 3, 2022, 8:02 am
Cloudflare: high revenue growth with cybersecurity tailwinds
Cloudflare is a leading content delivery network (CDN) which has achieved high revenue growth of over 5...
May 3, 2022, 7:53 am
Civeo: shares can still go higher
Performance achieved by Civeo Corp has been stellar over the past several months. This applies to the f...
May 2, 2022, 11:05 pm
Mettler-toledo international inc. announces webcast of presentation at the bofa securities 2022 healthcare conference
Columbus, OH, May 02, 2022 (GLOBE NEWSWIRE) -- Mettler-Toledo International Inc. (NYSE:MTD) today announced the webcast of its presentation at the Bo...
May 2, 2022, 4:45 pm
Sibanye stillwater: an attractive play
Revenues for the six months ending December 31, 2021 were $5,461 million compared to $4,439 million at the end of December 2020. Annual production gui...
April 28, 2022, 4:34 am
Check out these actively managed esg funds from clearbridge
According to a study conducted by Pew Research Center, most adults in the U.S. favor the United States taking steps to achieve net-zero carbon emissio...
April 22, 2022, 8:23 pm
Tuya's dilemma and breakthrough: 2021 annual report analysis
Tuya's annual retention rate of premium customers remained higher than 99%, while the annual retention rate of its Top 100 IoT PaaS brand customers re...
April 22, 2022, 2:09 pm
Gratomic announces production of first batch of processed graphite from aukam plan in namibia
Gratomic Inc. (TSX-V:GRAT, OTCQX:CBULF) has announced the production of the first batch of processed graphite from its Aukam plan in Namibia - the sit...
April 22, 2022, 7:56 am
Edesa biotech: leader in developing treatments for covid-19 and acd
Edesa is one of 4 pharmaceutical companies that received a grant from the Canadian government to develop a drug to treat COVID-19. EB01 ...
April 18, 2022, 1:53 pm
Monro: undervalued and misunderstood
Investors in Monro have been punished in recent months as if the company was performing poorly from a fundamental perspective. Interestingly, performa...
April 17, 2022, 5:35 am
Dufry: thoughts ahead of fy 2022
Another interesting stock on travel recovery. The company is very well positioned to benefit from the major milestone ...
April 15, 2022, 7:51 am
Trade market uncertainty with low-volatility etfs
Investors may want to remain invested in the equity world but at the same time seek protection from a downside. This could be easily ...
April 13, 2022, 12:48 pm
Aura minerals reports lower q1 2022 gold equivalent production, on track to achieve guidance
(Kitco News) - Aura Minerals (TSX: ORA) said today that the company achieved total quarterly production...
April 12, 2022, 3:26 pm
Tencent to shut down its game streaming service
Tencent, the world's largest video games company, said it will shutter its game streaming platform Penguin Esports by June due to “changes in busine...
April 7, 2022, 5:50 pm
Canadian natural resources: 2022 - the year of the shareholder
The Net Debt targets have been achieved meaning 50% of free cash flow will now be used for buybacks....
April 5, 2022, 11:38 am
Nevada copper reports record monthly production at pumpkin hollow as ramp-up continues
(Kitco News) - Nevada Copper (TSX: NCU) today announced positive operations advances at its Pumpkin Hollow project, including record monthly productio...
April 4, 2022, 3:51 pm
Spotify's plan for growth faces a real obstacle
Spotify is clear on where it expects its growth to come from. However, SPOT stock is a hold until they prove the plan can be achieved....
April 2, 2022, 9:15 am
Todos medical reports case study of patient with long covid who used its dietary supplement tollovid after doctor recommendation
Todos Medical Ltd announced that its majority-owned subsidiary 3CL Pharma, Ltd is reporting a case study from a patient with long COVID who was re...
March 31, 2022, 1:57 pm
Clovis oncology's rubraca significantly improves pfs in ovarian cancer regardless of biomarker status
Clovis Oncology Inc (NASDAQ: CLVS) announced positive topline data from the monotherapy arm of Phase 3 ATHENA-MONO trial of Rubraca (Rucaparib) as ...
March 31, 2022, 9:34 am